MOH — authorised 27 August 2018
- Marketing authorisation holder: TETRAPHASE PHARMS
- Status: likely_approved
🇮🇱 Xerava in Israel
MOH authorised Xerava on 27 August 2018
Marketing authorisation
Xerava in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Israel
Frequently asked questions
Is Xerava approved in Israel?
Yes. MOH authorised it on 27 August 2018.
Who is the marketing authorisation holder for Xerava in Israel?
TETRAPHASE PHARMS holds the Israeli marketing authorisation.